November 16, 2016 - By Dolores Ford · 0 Comments
Intermolecular Inc (NASDAQ:IMI) institutional sentiment decreased to 1.13 in Q2 2016. Its down -0.37, from 1.5 in 2016Q1. The ratio fall, as 17 active investment managers started new or increased stock positions, while 15 reduced and sold their stock positions in Intermolecular Inc. The active investment managers in our partner’s database now hold: 19.16 million shares, up from 19.08 million shares in 2016Q1. Also, the number of active investment managers holding Intermolecular Inc in their top 10 stock positions decreased from 1 to 0 for a decrease of 1. Sold All: 7 Reduced: 8 Increased: 9 New Position: 8.
Intermolecular, Inc. provides thin film solutions. The company has a market cap of $62.05 million. The Company’s high productivity combinatorial platform, which consists of its tempus processing tools, its automated characterization methods, and its Informatics analysis software, is purpose-built for research and development (R&D) using combinatorial process systems. It currently has negative earnings. It develops technology and Internet protocol (IP) rights focused on materials, processes, integration and device architectures in collaboration with its customers.
The stock closed at $1.05 during the last session. It is down 56.25% since April 14, 2016 and is downtrending. It has underperformed by 60.94% the S&P500.
According to Zacks Investment Research, “Intermolecular, Inc. provides high productivity combinatorial technology products and services in order to accelerate research and development, innovation and time-to-market for the semiconductor and clean-energy industries. It also develops technology and intellectual property for its customers. The Company’s customers include semiconductor device, semiconductor materials and equipment, and clean-energy companies. Intermolecular, Inc. is headquartered in San Jose, California.”
Raging Capital Management Llc holds 2.58% of its portfolio in Intermolecular Inc for 11.35 million shares. Symmetry Peak Management Llc owns 1.02 million shares or 0.25% of their US portfolio. Moreover, Grt Capital Partners L.L.C. has 0.02% invested in the company for 44,500 shares. The Texas-based Bridgeway Capital Management Inc has invested 0.01% in the stock. Employees Retirement System Of Texas, a Texas-based fund reported 347,602 shares.#img1#
Insider Transactions: Since January 1, 0001, the stock had 3 buys, and 0 sales for $2.34 million net activity.
Intermolecular, Inc., incorporated on June 16, 2004, provides solutions for the evaluation and development of engineered thin-film materials for next generation technology products. The Firm is a partner for the innovation of advanced materials using high throughput experimentation. The Company’s high productivity combinatorial (HPC) platform consists of tempus processing tools, automated characterization methods, and Informatics analysis software, which is purpose-built for research and development (R&D) using combinatorial process systems in concert with established chemical vapor deposition (CVD), physical vapor deposition (PVD) and atomic layer deposition (ALD) deposition methods. Combinatorial processing is a methodology for experimentation, discovery and development that employs parallel and other high-throughput experimentation. It begins the development and discovery process by working with its clients to define the specific requirements.
More notable recent Intermolecular Inc (NASDAQ:IMI) news were published by: Prnewswire.com which released: “Intermolecular Announces Third Quarter 2016 Financial Results” on November 02, 2016, also Prnewswire.com with their article: “Intermolecular To Report Third Quarter Fiscal 2016 Financial Results on …” published on October 13, 2016, Prnewswire.com published: “Purcell Julie & Lefkowitz LLP Is Investigating Intermolecular, Inc. for …” on April 20, 2016. More interesting news about Intermolecular Inc (NASDAQ:IMI) were released by: Thestreet.com and their article: “Why Intermolecular (IMI) Is Down Today” published on February 28, 2014 as well as Prnewswire.com‘s news article titled: “Intermolecular Appoints Chris Kramer President and CEO” with publication date: August 04, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Dolores Ford